Loading...

Silence Therapeutics plc

SLNCF•PNK
Healthcare
Biotechnology
$2.36
$0.00(0.00%)
U.S. Market opens in 16h 31m

Silence Therapeutics plc (SLNCF) Stock Overview

Explore Silence Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap334.4M
P/E Ratio-3.77
EPS (TTM)$-0.63
ROE-3.59%
Fundamental Analysis

AI Price Forecasts

1 Month$1.31
3 Months$3.53
1 Year Target$1.09

SLNCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Silence Therapeutics plc (SLNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.77 and a market capitalization of 334.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
18.00%
3-Month Change
47.50%
6-Month Change
47.50%
Year-to-Date (YTD) Change
18.00%
1-Year Change
143.30%
3-Year Change
-5.60%
5-Year Change
-68.53%
All-Time (Max) Change
-5.60%

Contact Information

https://www.silence-therapeutics.com
44 20 3457 6900
72 Hammersmith Road, London, NaN, W14 8TH

Company Facts

116 Employees
IPO DateSep 25, 2012
CountryGB
Actively Trading

Frequently Asked Questions